LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Treadwell Therapeutics, Inc.

Similar companies to Treadwell Therapeutics, Inc.

Treadwell Therapeutics, Inc. Tech Stack

Treadwell Therapeutics, Inc. uses 8 technology products and services including Limelight, Cloudflare, MySQL, and more. Explore Treadwell Therapeutics, Inc.'s tech stack below.

  • Limelight
    Content Delivery Network
  • Cloudflare
    Content Management System
  • MySQL
    Database
  • Google Cloud
    Infrastructure As A Service
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Slick
    Javascript Libraries
  • Nginx
    Web Servers

Media & News

Treadwell Therapeutics, Inc.'s Email Address Formats

Treadwell Therapeutics, Inc. uses at least 1 format(s):
Treadwell Therapeutics, Inc. Email FormatsExamplePercentage
F.Last@treadwelltx.comJ.Doe@treadwelltx.com
49%
FirstLast@treadwelltx.comJohnDoe@treadwelltx.com
2%
F.Last@treadwelltx.comJ.Doe@treadwelltx.com
49%

Frequently Asked Questions

Where is Treadwell Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Treadwell Therapeutics, Inc.'s main headquarters is located at New York, NY US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Treadwell Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Treadwell Therapeutics, Inc.'s official website is treadwelltx.com and has social profiles on LinkedIn.

How much revenue does Treadwell Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of October 2024, Treadwell Therapeutics, Inc.'s annual revenue reached $1.8M.

What is Treadwell Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Treadwell Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Treadwell Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2024, Treadwell Therapeutics, Inc. has approximately 25 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: R. S.Chief Financial Officer: T. S.Vice President Corporate Development: R. D.. Explore Treadwell Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Treadwell Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Treadwell Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Treadwell Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Treadwell Therapeutics, Inc.'s tech stack includes LimelightCloudflareMySQLGoogle CloudjQuery MigratejQuerySlickNginx.

What is Treadwell Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Treadwell Therapeutics, Inc.'s email format typically follows the pattern of . Find more Treadwell Therapeutics, Inc. email formats with LeadIQ.

How much funding has Treadwell Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2024, Treadwell Therapeutics, Inc. has raised $91M in funding. The last funding round occurred on Nov 18, 2021 for $91M.

When was Treadwell Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Treadwell Therapeutics, Inc. was founded in 2019.
Treadwell Therapeutics, Inc.

Treadwell Therapeutics, Inc.

Biotechnology ResearchNew York, United States11-50 Employees

Treadwell Therapeutics is a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers by targeting critical tumor-specific vulnerabilities including aneuploidy and immunogenicity. The Company’s robust, internally developed pipeline includes novel small molecule drugs in single agent and combination studies. Lead candidate, CFI-400945, is a PLK4 inhibitor in multiple Phase 1 and Phase 2 trials including for TNBC, prostate cancer and AML. Additional product candidates include CFI-402257, a clinical stage TTK inhibitor, as well as CFI-402411, a preclinical HPK1 inhibitor (IND filing 1H20), which is positioned to be the first clinical stage small molecule modulator of a unique node of T cell activation and has a mechanism distinct from PD1/PDL1.   Interested in joining Treadwell Therapeutics?  Visit our Career page:  https://treadwelltx.com/careers/

Section iconCompany Overview

Headquarters
New York, NY US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $91M

    Treadwell Therapeutics, Inc. has raised a total of $91M of funding over 2 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $91M.

  • $10M

    Treadwell Therapeutics, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $91M

    Treadwell Therapeutics, Inc. has raised a total of $91M of funding over 2 rounds. Their latest funding round was raised on Nov 18, 2021 in the amount of $91M.

  • $10M

    Treadwell Therapeutics, Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.